Investigation of the role of rosmarinic acid treatment in regulating inflammation, cell damage, and angiogenesis in rat ovarian torsion and detorsion models by Uğur Değer (10393672)

“…Follicle cells and cells in the corpus luteum showed a decrease in vascular endothelial growth factor (VEGF) expression, while VEGF demonstrated a positive reaction in vascular endothelial cells and stromal cells. …”

Effect of deferiprone in HIV-infected primary cells: Apoptotic DNA fragmentation, deoxyhypusyl-eIF5A accumulation, and DOHH activity. by Deepti Saxena (462177)

“…<p>Apoptotic DNA fragmentation (Panel A) was detected by terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) of single-donor peripheral blood mononuclear cells, maintained in short-term non-replenished cultures as described [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0154842#pone.0154842.ref043" target="_blank">43</a>]. …”

Annual cardiopulmonary arrest (CPA) incidence, case-mix index, and rapid response team dose trends. by Myung Jin Song (8780570)

HbA1c dynamics in patient groups in 6–8 weeks after discharge. by Marina Shestakova (4530472)

Supplementary Figure 1 by Rajesh Gupta (65584)

“…Fasting (and incubation in 100 µM nicotinic acid) led to a significant decrease in the PPR in GPR109A+/+ mice (as seen in C57BL/6J mice; compare with Figure 6A). …”

A Framework for Proactive Interaction in Automated Vehicles by Jinglu Li (16487649)

“…We find that when goals are misaligned, communicating contextual awareness decreases user experience and acceptance. As a result, if alignment of (immediate) goals is not possible—such as when drivers want to reduce walking distance but the closest parking lot is full—systems should exercise care in communicating their situation awareness, as this can reinforce users’ negative perceptions. …”

Mutations in p38 MAP kinase components and the mucolipin ortholog CUP-5 suppress the decrease in abundance of RAB-7 in <i>madd-3</i> mutants. by Serena A. D’Souza (2635801)

Mutations in p38 MAP kinase components and the mucolipin ortholog CUP-5 suppress the decrease in abundance of EVA-1 in <i>madd-3</i> mutants. by Serena A. D’Souza (2635801)

Table_1_Intramolecular Interactions Dominate the Autoregulation of Escherichia coli Stringent Factor RelA.pdf by Kathryn Jane Turnbull (7313054)

“…Second, in our biochemical assays, increasing RelA concentration does not decrease the enzyme activity, as would be expected in the case of efficient auto-inhibition via dimerization. …”

Ectopically expressed hNaa40p in yeast acetylates histone H4 but not H2A <i>in vivo</i>. by Kristine Hole (205643)

“…Various N-acetylated forms of these histone N-termini were detected in all samples analyzed. A decrease of 5 Da, corresponds with the gain of an extra <i>in vivo</i> N-acetyl group (i.e. all free amines were <i>in vitro</i> N-acetylated using ¹³C₂D₃-NHS acetate; i.e. adding a 5 Da heavier acetyl group to free amines). …”

Clade-Specific Quantitative Analysis of Photosynthetic Gene Expression in <i>Prochlorococcus</i> by María-Carmen Fernández-Pinos (779920)

“…Laboratory exposure of <i>Prochlorococcus</i> MED4 (HL) and MIT9313 (LL) strains to organic pollutants (PAHs and organochlorine compounds) showed a decrease of <i>rbc</i>L transcript abundances, and of the <i>rbc</i>L to <i>psb</i>A ratios for both strains. …”

Table_1_Effects of Uric Acid-Lowering Treatment on Glycemia: A Systematic Review and Meta-Analysis.DOCX by Juan Chen (61123)

“…</p><p>Results: Four trials with 314 patients reported the effect of ULT with allopurinol on FBG and 2 trials with 141 patients reported the effect of ULT with allopurinol on HbA1c. Treatment with allopurinol resulted in a significant decrease in FBG (WMD: −0.61 mmol/L, 95% CI: −0.93 to −0.28), but only a trend of reduction in HbA1c (WMD: −0.47%, 95% CI: −1.16 to 0.22). …”

A representative ultrasound axis image. by Eun-Seon Yang (19751340)

“…This suggests that low-pressure VM can be a simple and cost-effective method to reduce cerebrovascular stiffness in a brief interval, without the need for specific environmental conditions.…”

Table_1_Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.docx by Gunaraj Dhungana (11276481)

“…However, the pharmacokinetics (PK) and pharmacodynamics (PD) of phage therapy are largely unknown. In the present study, we aimed to evaluate the PK/PD of a locally isolated virulent novel øKp_Pokalde_002 (Podoviridae, C1 morphotype) that infects carbapenem-resistant Klebsiella pneumoniae (Kp56) using oral and intraperitoneal (IP) route in a mouse model. …”

Image_1_Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.jpeg by Gunaraj Dhungana (11276481)

“…However, the pharmacokinetics (PK) and pharmacodynamics (PD) of phage therapy are largely unknown. In the present study, we aimed to evaluate the PK/PD of a locally isolated virulent novel øKp_Pokalde_002 (Podoviridae, C1 morphotype) that infects carbapenem-resistant Klebsiella pneumoniae (Kp56) using oral and intraperitoneal (IP) route in a mouse model. …”

Table_2_Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.docx by Gunaraj Dhungana (11276481)

“…However, the pharmacokinetics (PK) and pharmacodynamics (PD) of phage therapy are largely unknown. In the present study, we aimed to evaluate the PK/PD of a locally isolated virulent novel øKp_Pokalde_002 (Podoviridae, C1 morphotype) that infects carbapenem-resistant Klebsiella pneumoniae (Kp56) using oral and intraperitoneal (IP) route in a mouse model. …”

Image_2_Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.jpeg by Gunaraj Dhungana (11276481)

“…However, the pharmacokinetics (PK) and pharmacodynamics (PD) of phage therapy are largely unknown. In the present study, we aimed to evaluate the PK/PD of a locally isolated virulent novel øKp_Pokalde_002 (Podoviridae, C1 morphotype) that infects carbapenem-resistant Klebsiella pneumoniae (Kp56) using oral and intraperitoneal (IP) route in a mouse model. …”

Table_3_Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.docx by Gunaraj Dhungana (11276481)

“…However, the pharmacokinetics (PK) and pharmacodynamics (PD) of phage therapy are largely unknown. In the present study, we aimed to evaluate the PK/PD of a locally isolated virulent novel øKp_Pokalde_002 (Podoviridae, C1 morphotype) that infects carbapenem-resistant Klebsiella pneumoniae (Kp56) using oral and intraperitoneal (IP) route in a mouse model. …”

Image_3_Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.jpeg by Gunaraj Dhungana (11276481)

“…However, the pharmacokinetics (PK) and pharmacodynamics (PD) of phage therapy are largely unknown. In the present study, we aimed to evaluate the PK/PD of a locally isolated virulent novel øKp_Pokalde_002 (Podoviridae, C1 morphotype) that infects carbapenem-resistant Klebsiella pneumoniae (Kp56) using oral and intraperitoneal (IP) route in a mouse model. …”

Graphs depicting the material mineralization of the cortex at the (A) Condyle, (B) Attachment of the masseter, (C) The part below the second tooth. by Natsuko Hichijo (752937)